Cargando…
A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models
Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus capable of causing a severe hemorrhagic fever disease in humans. There are currently no licensed vaccines to prevent CCHFV-associated disease. We developed a DNA vaccine expressing the M-segment glycoprotein precursor gene of CCHFV...
Autores principales: | Garrison, Aura R., Shoemaker, Charles J., Golden, Joseph W., Fitzpatrick, Collin J., Suschak, John J., Richards, Michelle J., Badger, Catherine V., Six, Carolyn M., Martin, Jacqueline D., Hannaman, Drew, Zivcec, Marko, Bergeron, Eric, Koehler, Jeffrey W., Schmaljohn, Connie S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5619839/ https://www.ncbi.nlm.nih.gov/pubmed/28922426 http://dx.doi.org/10.1371/journal.pntd.0005908 |
Ejemplares similares
-
A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice
por: Suschak, John J., et al.
Publicado: (2021) -
GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection
por: Golden, Joseph W., et al.
Publicado: (2019) -
Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis
por: Smith, Darci R., et al.
Publicado: (2019) -
Animal Models for Crimean-Congo Hemorrhagic Fever Human Disease
por: Garrison, Aura R., et al.
Publicado: (2019) -
The host inflammatory response contributes to disease severity in Crimean-Congo hemorrhagic fever virus infected mice
por: Golden, Joseph W., et al.
Publicado: (2022)